Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abeona Therapeutics (ABEO) Net Cash Flow: 2011-2024

Historic Net Cash Flow for Abeona Therapeutics (ABEO) over the last 14 years, with Dec 2024 value amounting to $8.9 million.

  • Abeona Therapeutics' Net Cash Flow fell 331.29% to -$80.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $67.2 million, marking a year-over-year increase of 509.75%. This contributed to the annual value of $8.9 million for FY2024, which is 3370.31% up from last year.
  • Per Abeona Therapeutics' latest filing, its Net Cash Flow stood at $8.9 million for FY2024, which was up 3,370.31% from $256,000 recorded in FY2023.
  • In the past 5 years, Abeona Therapeutics' Net Cash Flow ranged from a high of $25.3 million in FY2021 and a low of -$116.8 million during FY2020.
  • For the 3-year period, Abeona Therapeutics' Net Cash Flow averaged around -$5.0 million, with its median value being $256,000 (2023).
  • In the last 5 years, Abeona Therapeutics' Net Cash Flow crashed by 205.17% in 2020 and then soared by 3,370.31% in 2024.
  • Over the past 5 years, Abeona Therapeutics' Net Cash Flow (Yearly) stood at -$116.8 million in 2020, then surged by 121.63% to $25.3 million in 2021, then tumbled by 196.10% to -$24.3 million in 2022, then soared by 101.05% to $256,000 in 2023, then surged by 3,370.31% to $8.9 million in 2024.